Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regina Paleski

Advertisement
Set Alert for Articles By Regina Paleski

Latest From Regina Paleski

Execs On The Move, June 2019

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership Appointments

Executives On The Move: Changes At Amgen, Novartis and EyePoint

Amgen commercial lead takes up top sales post at Adamas Pharmaceuticals and a Novartis Oncology VP switches to SVP, Americas Commercial Oncology at Eisai Inc. Also, EyePoint Pharma announces its new chief commercial officer is now on board.

Appointments BioPharmaceutical

Executives On The Move: C-level Promotions At German Merck and Vericel, And Faron Pharma Names A CFO

Merck KGaA promotes auditing head to Chief Compliance Officer and cell-therapy firm Vericel moves up quality/regulatory exec to COO. Finnish late-stage drug company Faron Pharmaceuticals hires a Danaher Group finance leader for CFO.

Appointments BioPharmaceutical

Executives On The Move: Sanofi Acquires Development Talent And Senior Leadership Exits At Biogen And Bristol-Myers Squibb

French multinational pharma Sanofi taps cancer specialist for head of development and global rare disease firm CSL Behring hires former Biogen EVP as COO. At Gilead Sciences, a new chief commercial officer joins from Bristol-Myers Squibb.

Appointments BioPharmaceutical

Executives On The Move: Management Changes At Voyager Therapeutics, AstraZeneca and Celsius Therapeutics

This week’s appointments include a promotion at Voyager Therapeutics as its CMO takes on the additional role of head of R&D and a departure at AstraZeneca as a VP, oncology moves to Seattle Genetics to the chief commercial officer spot. At Celsius Therapeutics, a new CBO is hired.

 

 

 

 

 

Appointments BioPharmaceutical

Execs On The Move, May 2019

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Commercial Appointments
See All
Advertisement
UsernamePublicRestriction

Register